当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い
。オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル と 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得
Richard Bradley
This is a case study of a 34-year-old man who has had chronic spontaneous urticaria (CSU) for 17 years and has been experiencing severe generalized itching and rashes all over his body. Omalizumab (OMA), autologous serum therapy (AST), and conventional antihistamine treatments do not significantly alleviate the patient's symptoms. Snehapana (therapeutic administration of unctuous formulations like ghee, oil), Vamana, Virechana, and internal medication in line with Seethapitta Chikitsa were some of the Ayurvedic Panchakarma procedures used to treat him. At baseline, after Vamana, after Virechana, and at follow-up, the patient was instructed to use a validated weekly Urticaria Activity Score (UAS7) to keep track of hives and itching for a week. The Chronic Urticaria Quality of Life Questionnaire (CU-Q2oL) was used to measure quality of life at baseline and during follow-up. According to the scores, the assessment revealed a complete remission of disease activity and an improvement in quality of life. The hematological and biochemical investigations demonstrate that Ayurveda is safe and effective in managing CSU.